Farzad Nazem insider trades

Open-market stock purchases and sales by Farzad Nazem, Director at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Jun 15, 2022.

Recent trades

DateStockTradeValue
Jun 18, 2026NAUT Nautilus Biotechnology, IncBought (not open market)—

Companies traded

  • NAUT Nautilus Biotechnology, Inc: other filings, last Jun 18, 2026

Get free alerts when Farzad Nazem files a new trade →